MEDICATION ASSISTED TREATMENT/OPIOID ABUSE/ADDICTION
- White House to Request $1 Billion to Counter Drug Abuse Epidemic
- Violent Crime Lower Near Drug Treatment Centers Than Other Commercial Areas
- Revised Opioid Overdose Toolkit Now Available From SAMHSA
- Survey Results – Opioid Abuse and Misuse: Providers and Patients Speak Up
- Use of Psychosocial Treatments in Conjunction With Medication for Opioid Addiction—Recommended, But Research Is Sparse
- Educate Doctors, Treat Addicts to Curb Opioid Abuse, Lawmakers Told
- News From Massachusetts: Data Show Opioids’ Deadly Toll
- VA Docs Defied Opiate Rules in Treating Vets, Audit Finds
- Research Article Abstract: Drug Test Results as a Predictor of Retention among Patients Using Buprenorphine in a Comprehensive Outpatient Treatment Program
- SAMHSA Selects Kimberly A. Johnson, Ph.D., As CSAT Director
- Review Article Reinforces Support for Brain Disease Model of Addiction (NIDA)
LINKS TO ADDITIONAL NATIONAL NEWS OF INTEREST
- Research results: The dose makes the poison: Opioid overdose study supports call for caution in Rx levels – 2/1/16
- Amid heroin crisis, GOP contenders reframe addiction as a health crisis – 2/1/16
- Congress tackles the issue of opioid abuse, echoing talk on campaign trail – 1/29/16
- Senate Response to Opioid Abuse Could Hit FDA, Drugmakers – 1/27/16
- Dr. Jana Burson Blog: After the Overdose – 1/23/16
Categories: 2016-02-05, News Updates, TOC
“The White House on Tuesday proposed $1 billion in new funding over two years to fight heroin and prescription drug abuse.
The proposal in President Obama’s budget reflects an increased push to combat the opioid epidemic, one of the few areas where both parties see the potential for bipartisan action in Congress this year.
Almost all of the new money, $920 million, would be for mandatory funding over two years for states to increase medication-assisted treatment, which also involves therapy, for people with opioid use disorders.
Secretary of Health and Human Services Sylvia Burwell said on a call with reporters that 2.2 million people need treatment for opioid abuse, but only about one million people are receiving it
The new funding would require approval from Congress, but officials pointed to bipartisan support for doing something about the opioid crisis.”
Source: TheHill.com – February 2, 2016
For more information on how the proposed funding would be allocate see FACT SHEET: President Obama Proposes $1.1 Billion in New Funding to Address the Prescription Opioid Abuse and Heroin Use Epidemic issue by the White House available at: https://www.whitehouse.gov/the-press-office/2016/02/02/president-obama-proposes-11-billion-new-funding-address-prescription
Categories: Heroin, Medication-Assisted Treatment (MAT), News Updates, Opioid Abuse/Addiction, Prescription Drugs
Tags: Addiction, Buprenorphine, Government, Heroin, Methadone Treatment, Prescription Opioids, Substance abuse treatment
Baltimore findings offer empirical evidence to counter claims that methadone and other outpatient clinics attract criminal element.
“Despite conventional wisdom that outpatient drug treatment centers such as methadone clinics bring violent crime into the neighborhoods where they sit, new Johns Hopkins Bloomberg School of Public Health research suggests there may actually be less serious crime near clinics than other community businesses.
The researchers, publishing in the January issue of the Journal of Studies on Alcohol and Drugs, compared 2011 violent crime statistics near 53 publicly funded treatment centers in Baltimore and found that the areas around 53 comparable liquor stores and corner stores saw significantly more homicides, rapes, aggravated assaults and robberies per business than the areas around drug treatment centers.
The researchers say these findings strike a blow to the argument many use to keep new treatment centers from being opened in their neighborhoods, that the coming and going of drug addicts receiving daily methadone and other treatment brings with it a dangerous element.”
Source: Johns Hopkins Bloomberg School of Public Health – January 27, 2016
Categories: 2016-02-05, Addiction, Medication-Assisted Treatment (MAT), Methadone, News Updates, Opioid Abuse/Addiction, Opioid Treatment Programs (OTPs), Opioids
Tags: Methadone Treatment, Opioid Treatment Programs, Stigma, Substance abuse treatment
SAMHSA has released a revised version of the Opioid Overdose Toolkit. This toolkit is designed to educate first responders, physicians, patients, family members, and community members on ways to prevent opioid overdose.
The revised content now includes information on the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can reverse the effects of an opioid overdose.
The toolkit provides information on:
- Facts for Community
- Five Essential Steps for First Responders
- Information for Prescribers
- Safety Advise for Patients & Family Members
- Recovering From Opioid Overdose
The updated toolkit is available for free download on the SAMHSA Store at: http://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit-Updated-2016/SMA16-4742
Source: SAMHSA.gov – January 2016
See related articles on overdose and naloxone:
Overdose Reversal Drug Now Available to Every U.S. High School Free Of Charge available at: http://www.huffingtonpost.com/entry/naloxone-overdose-reversal-high-schools_us_56a68951e4b0404eb8f29097
Naloxone, Fast-Acting Treatment For Heroin Overdoses, Now Free For Schools: Controversy Ensues available at: http://www.medicaldaily.com/naloxone-heroin-overdose-schools-371316
Categories: 2016-02-05, Addiction, News Updates, Opioid Abuse/Addiction, Opioids
Tags: Heroin, naloxone, Overdose, Prescription Opioids
“When used properly, opioid analgesics can be extremely effective therapies. When misused or abused, however, the agents can have dire consequences, as we’ve seen with the recent rise in morbidity and mortality associated with opioid use. According to the Centers for Disease Control and Prevention (CDC), in 2012, US providers wrote 259 million prescriptions for painkillers, enough for every American adult to have a bottle of pills. The CDC also reports that 46 Americans die every day from overdosing on prescription painkillers.
As part of a commitment to the White House calling on public and private organizations to help address prescription drug and heroin abuse, WebMD and Medscape recently conducted a survey exploring patient and prescriber attitudes about and experience with opioids. Read on for the results.”
Source: Medscape.com – January 28, 2016
Categories: 2016-02-05, News Updates, Opioid Abuse/Addiction, Opioids, Prescription Drugs, Research/Surveys
Tags: Addiction, Prescription Opioids, Research
Use of Psychosocial Treatments in Conjunction With Medication for Opioid Addiction—Recommended, But Research Is Sparse
“Psychosocial interventions, used together with effective medications, are a key part of recommended treatment for opioid addiction. But while research generally supports the effectiveness of psychosocial treatments, there are major gaps in the evidence on their use in conjunction with medications, according to a review and update in the January/February Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM).
“Given the current state of the opioid overdose epidemic, it is critical that patients seeking help for opioid addiction have access to comprehensive treatment that includes highly effective medications whose effects may be enhanced with the provision of psychosocial interventions,” according to the report by Karen Dugosh, PhD, of Treatment Research Institute, Philadelphia, and colleagues.
Of the 27 newer studies, 14 evaluated psychosocial treatments in conjunction with methadone maintenance therapy. Nine of these studies showed significant benefits of psychosocial interventions in patients being treated with methadone, including reduced drug use and increased treatment attendance. For buprenorphine, the results were “less robust”—only three of eight studies found positive effects of psychosocial interventions.
The study results are available at: http://medicalxpress.com/news/2016-01-psychosocial-treatments-conjunction-medication-opioid.html
Source: MedicalExpress.com – January 26, 2016
Categories: 2016-02-05, Addiction, Buprenorphine, Heroin, Medication-Assisted Treatment (MAT), News Updates, Opioid Abuse/Addiction, Opioid Treatment Programs (OTPs), Opioids, Research/Surveys
Tags: Heroin, Methadone Treatment, Opioid Treatment Programs, Prescription Opioids, Substance abuse treatment
“Curbing the nation’s heroin epidemic, which has emerged as a major election-year concern among voters, will require educating physicians about their prescribing patterns, and providing more funding for behavioral-health professionals and medication-assisted treatments, lawmakers on the Senate Judiciary Committee were told Wednesday.
Senators from both sides of the aisle expressed support for policy prescriptions offered by three panels of expert witnesses, including public-health officials and law-enforcement officers. Sen. Kelly Ayotte (R-N.H.) urged the committee to take action on the Comprehensive Addiction and Recovery Act, which was first introduced in 2014.
Senators from both parties said they were encouraged by their colleagues’ statements, and would push for the bill to move toward a vote. Presidential candidates from both parties have also called for action on the opioid-abuse epidemic.”
Source: ModernHealthcare.com – January 27, 2016
See related article: Testimony from Linda Hurley (CODAC RI) to the Senate Committee on the Judiciary hearing on: “Attacking America’s Epidemic of Heroin and Prescription Drug Abuse.” Available at: http://www.judiciary.senate.gov/imo/media/doc/01-27-16%20Hurley%20Testimony.pdf
See related article: Vermont Governor Testifies On Addiction Crisis in Washington available at:
Categories: 2016-02-05, Heroin, News Updates, Opioids
Tags: Addiction, Heroin, Prescription Opioids
People 25 to 44 years old are hardest hit by the opioid overdose epidemic that has left thousands dead in Massachusetts, according to new data from the state Department of Public Health.
On Wednesday, the state released for the first time a demographic portrait of the still-growing health crisis, and that report found certain groups bear a disproportionate burden.
The numbers show that overdose deaths in the first nine months of 2015 remained high — higher than the same period the year before, despite policy-makers’ focus on combating heroin and prescription painkiller abuse.
Fifty-seven percent of those who died of unintentional overdoses were 25 to 44 years old, even though this age group accounted for only 4 percent of deaths from all causes during that period. Ten percent of overdose deaths were among those younger than 25, while only 1.5 percent of all deaths were among people that young.
Hispanic people are also disproportionately affected. Nine percent of people who died of overdoses were Hispanic, compared with 3 percent of those who died from all causes.
Still, most of those who died from unintentional overdoses — 83 percent — were white non-Hispanic people.
And men were substantially more likely to succumb from powerful drugs: Three-quarters of those who died of unintentional opioid overdoses were men.
Source: BostonGlobe.com – 1/21/16
See related article from the New York Times: Drug Overdoses Propel Rise in Mortality Rates of Young Whites available at:
Categories: 2016-02-05, Heroin, News Updates, Opioid Abuse/Addiction, Overdose
Tags: Heroin, Overdose, Prescription Opioids
“VA medical centers defied some agency policies on supplying opiates to veterans in 2012, including simultaneously prescribing thousands of ex-troops with narcotic painkillers and psychoactive drugs -– a combination that’s been linked to lethal overdoses, a new audit shows. The review, conducted by the independent Veterans Affairs Office of Inspector General (OIG), found that 92.6 percent of veterans who are chronically prescribed opioid drugs (such as Oxycodone) also were prescribed benzodiazepines (such as Xanax and Valium) -– a mix “strongly associated with death from opioid overdose.”
The audit, which collected data from a population of about a half million veterans, was first reported on by the Center for Investigative Reporting. In addition, about one third of the veterans prescribed opioids “were on take-home opioids for more than 90 days,” the audit showed. The U.S. Department of Veterans Affairs’ own clinical practice guidelines already urge, the auditors note, “more careful monitoring of opioid patients treated with benzodiazepines as co-administration of these products may result in adverse drug interactions.”
Among the VA’s “take-home opioid patients,” 7,426 died in fiscal year 2012, states the report, which did not breakdown the causes of those deaths. The audit –- requested by the Senate Committee on Veterans Affairs –- also found that while VA rules mandate veterans prescribed opiates undergo urine pre-tests to block addiction, only 7.6 percent of new veteran patients were given a urine drug test within 30 days prior to initiating their opioid therapy.”
Read more at: http://web9blog.com/article?id=577103
Source: Web9Blog.com – January 24, 2015
Categories: 2016-02-05, News Updates, Opioid Abuse/Addiction, Opioids
Tags: Addiction, Benzodiazepines, Prescription Opioids, Veterans
Research Article Abstract: Drug Test Results as a Predictor of Retention among Patients Using Buprenorphine in a Comprehensive Outpatient Treatment Program
The study examined the relationship between continued nonmedical drug use and treatment retention for patients receiving buprenorphine maintenance treatment (BMT) in a comprehensive addiction treatment program.
Newly admitted patients testing positive for drugs more than 33% of the time were significantly more likely than those with less frequent or no positive tests to withdraw from treatment within two months. Continuing patients with at least one positive drug test left treatment six months sooner, on average, than those with no positive tests and were twice as likely to leave without
completing continuing care (87% to 42%).
Nonprescribed drug use during BMT is strongly correlated with lowered retention and risk of early treatment termination for new and continuing patients. Actions taken to monitor and reduce drug use during BMT may improve retention and enhance long-term recovery outcomes.
The abstract is available at: http://www.ncbi.nlm.nih.gov/pubmed/26757093
Source: Journal of Addictive Disorders – January 2016
Categories: 2016-02-05, Medication-Assisted Treatment (MAT), News Updates, Opioid Abuse/Addiction
Tags: Addiction, Buprenorphine, Prescription Opioids, Research, Substance abuse treatment
SAMHSA announced the selection of Kimberly A. Johnson, Ph.D., as the permanent Director of the Center for Substance Abuse Treatment (CSAT). In her new role, Dr. Johnson will be responsible for the leadership, management, and operations of CSAT’s more than $2 billion budget with a significant portfolio of grants and contracts to states, tribes, territories, communities, and nonprofit organizations. She will begin her role at SAMHSA on February 22, 2016.
She is currently the deputy director for operations of CHESS/NIATx, a research center at the University of Wisconsin, Madison that focuses on systems improvement in behavioral health and the development of mobile applications for patient self-management. Dr. Johnson is also co-director of the national coordinating office of the Addiction Technology Transfer Center. Prior to her move to Wisconsin, she served for seven years as the director of the Office of Substance Abuse in Maine. In her work with the State of Maine, Dr. Johnson provided leadership in identifying and treating the opioid epidemic. This included developing plans to reduce misuse and increase access to treatment including medication assisted treatment, and equipping first responders with Narcan. She also served as executive director of Crossroads for Women, a women’s addiction treatment agency. In addition, Dr. Johnson managed community-based intervention and prevention programs and provided counseling for individuals and families as a child and family therapist.
Source: Substance Abuse and Mental Health Services Administration – February 4, 2016
Categories: 2016-02-05, News Updates
Tags: SAMHSA, Substance abuse treatment